Active Nuclear Receptors Exhibit Highly Correlated AF-2 Domain Motions

Nuclear receptor ligand binding domains (LBDs) convert ligand binding events into changes in gene expression by recruiting transcriptional coregulators to a conserved activation function-2 (AF-2) surface. While most nuclear receptor LBDs form homo- or heterodimers, the human nuclear receptor pregnane X receptor (PXR) forms a unique and essential homodimer and is proposed to assemble into a functional heterotetramer with the retinoid X receptor (RXR). How the homodimer interface, which is located 30 Å from the AF-2, would affect function at this critical surface has remained unclear. By using 20- to 30-ns molecular dynamics simulations on PXR in various oligomerization states, we observed a remarkably high degree of correlated motion in the PXR–RXR heterotetramer, most notably in the four helices that create the AF-2 domain. The function of such correlation may be to create “active-capable” receptor complexes that are ready to bind to transcriptional coactivators. Indeed, we found in additional simulations that active-capable receptor complexes involving other orphan or steroid nuclear receptors also exhibit highly correlated AF-2 domain motions. We further propose a mechanism for the transmission of long-range motions through the nuclear receptor LBD to the AF-2 surface. Taken together, our findings indicate that long-range motions within the LBD scaffold are critical to nuclear receptor function by promoting a mobile AF-2 state ready to bind coactivators.

[1]  Denise G. Teotico,et al.  Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole , 2007, Oncogene.

[2]  Matthew D Krasowski,et al.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts. , 2005, Molecular endocrinology.

[3]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[4]  Birgit Schiøtt,et al.  Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. , 2007, Biochemistry.

[5]  C. Carlberg,et al.  Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. , 2006, Current topics in medicinal chemistry.

[6]  R. Fletterick,et al.  Discovery of Small Molecule Inhibitors of the Interaction of the Thyroid Hormone Receptor with Transcriptional Coregulators* , 2005, Journal of Biological Chemistry.

[7]  R W Harrison,et al.  Variational calculation of the normal modes of a large macromolecule: methods and some initial results. , 1984, Biopolymers.

[8]  R. Fletterick,et al.  A High-Throughput Screening Method to Identify Small Molecule Inhibitors of Thyroid Hormone Receptor Coactivator Binding , 2006, Science's STKE.

[9]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[10]  P. Chambon,et al.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. , 1995, Nature.

[11]  E. Purisima,et al.  Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. , 2006, Human molecular genetics.

[12]  M. Karplus,et al.  Normal modes for specific motions of macromolecules: application to the hinge-bending mode of lysozyme. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Sean Ekins,et al.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. , 2002, Pharmaceutical research.

[14]  K. Hinsen.  Analysis of domain motions by approximate normal mode calculations , 1998, Proteins.

[15]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[16]  Denise G. Teotico,et al.  The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. , 2005, Molecular endocrinology.

[17]  Dusanka Janezic,et al.  Harmonic analysis of large systems. I. Methodology , 1995, J. Comput. Chem..

[18]  Hao Li,et al.  Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs , 2007, Clinical Cancer Research.

[19]  Rama Ranganathan,et al.  Structural Determinants of Allosteric Ligand Activation in RXR Heterodimers , 2004, Cell.

[20]  Timothy M Willson,et al.  Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. , 2007, Bioorganic & medicinal chemistry.

[21]  S. Kliewer,et al.  The nuclear pregnane X receptor regulates xenobiotic detoxification. , 2003, The Journal of nutrition.

[22]  Ralf Flaig,et al.  Structural Basis for the Deactivation of the Estrogen-related Receptor γ by Diethylstilbestrol or 4-Hydroxytamoxifen and Determinants of Selectivity* , 2004, Journal of Biological Chemistry.

[23]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[24]  M. Lambert,et al.  Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. , 2003, Journal of molecular biology.

[25]  Karsten Suhre,et al.  ElNémo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement , 2004, Nucleic Acids Res..

[26]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[27]  Y. Sanejouand,et al.  Conformational change of proteins arising from normal mode calculations. , 2001, Protein engineering.

[28]  Tirion,et al.  Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis. , 1996, Physical review letters.

[29]  Y. Liu,et al.  Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[30]  L. Moore,et al.  Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. , 2007, Molecular endocrinology.

[31]  L. Moore,et al.  Human PXR forms a tryptophan zipper-mediated homodimer. , 2006, Biochemistry.

[32]  B. Everitt,et al.  Cluster Analysis: Low Temperatures and Voting in Congress , 2001 .

[33]  C. Handschin,et al.  Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.

[34]  J. Schwabe,et al.  A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease , 2003, Nature Structural Biology.

[35]  Scott A. Busby,et al.  Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry. , 2006, Analytical chemistry.

[36]  J. Katzenellenbogen,et al.  Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. , 2002, Molecular endocrinology.

[37]  Sean Ekins,et al.  A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.

[38]  U. Brinkmann,et al.  Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[39]  Timothy M Willson,et al.  The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. , 2002, Endocrine reviews.

[40]  P. Chacón,et al.  Thorough validation of protein normal mode analysis: a comparative study with essential dynamics. , 2007, Structure.

[41]  Feng Ding,et al.  Multiscale modeling of nucleosome dynamics. , 2007, Biophysical journal.

[42]  Brian Everitt,et al.  Cluster analysis , 1974 .

[43]  S. Kliewer,et al.  Regulation of cyp3a gene transcription by the pregnane x receptor. , 2002, Annual review of pharmacology and toxicology.

[44]  G D Schuler,et al.  A workbench for multiple alignment construction and analysis , 1991, Proteins.

[45]  N Go,et al.  Normal mode analysis of human lysozyme: Study of the relative motion of the two domains and characterization of the harmonic motion , 1991, Proteins.

[46]  R G Smith,et al.  Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. , 2000, Journal of molecular biology.

[47]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[48]  M. Redinbo,et al.  Structural insights into the promiscuity and function of the human pregnane X receptor. , 2002, Current opinion in drug discovery & development.

[49]  Y. Sanejouand,et al.  Hinge‐bending motion in citrate synthase arising from normal mode calculations , 1995, Proteins.